Have a personal or library account? Click to login
A Randomized, Two-Treatments, Two-Periods, Crossover, Open label, Laboratory-Blind, Single Dose Bioequivalence Study between Vildagliptin/Metformin 50 mg/1000 mg Film Coated Tablets (Sensityn®) and Galvusmet® 50 mg/1000 mg Film Coated Tablets in healthy adults under fed conditions Cover

A Randomized, Two-Treatments, Two-Periods, Crossover, Open label, Laboratory-Blind, Single Dose Bioequivalence Study between Vildagliptin/Metformin 50 mg/1000 mg Film Coated Tablets (Sensityn®) and Galvusmet® 50 mg/1000 mg Film Coated Tablets in healthy adults under fed conditions

European Pharmaceutical Journal
Volume 70 (2023): Issue 2 (December 2023)
By: J. Shiekmydeen,  T. Siddiqi,  K. Chakraborty,  S. Khalaf,  M. Albarazi,  I. Eqtefan and  J. Sliva  
Open Access
|Oct 2023

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/afpuc-2023-0019 | Journal eISSN: 2453-6725
Journal RSS Feed
Language: English
Page range: 1 - 9
Submitted on: Aug 16, 2023
Accepted on: Aug 30, 2023
Published on: Oct 20, 2023
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
bioequivalence,
diabetes mellitus,
metformin,
pharmacokinetics,
vildagliptin
Related subjects:
Pharmacy,
Pharmacy, other

© 2023 J. Shiekmydeen, T. Siddiqi, K. Chakraborty, S. Khalaf, M. Albarazi, I. Eqtefan, J. Sliva, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 70 (2023): Issue 2 (December 2023)Next article